Screen for compounds synthetically lethal with defective RB and p53

Therapeutic Innovation Australia 2026 Open access

Read full text

Authors: Therapeutic Innovation Australia

DOI: 10.82292/sje9-sd81

Cited by: 0

Fields of Study & Subjects

Cancer-related Molecular Pathways PI3K/AKT/mTOR signaling in cancer Chromatin Remodeling and Cancer